Stephen Philip Jackson

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in DNA Repair Inhibitors. Top assignees: Kudos Pharmaceuticals Limited, Maybridge Limited, University of Cambridge. Active years: 2001-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Philip Jackson. Retrieved from https://idiyas.com/inventor/stephen-philip-jackson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 119(Granted Patents)

Company Filing History:

14 out of 36

Kudos Pharmaceuticals Limited

University of Cambridge

patents

4. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

5. 1 out of 1

Kudo Pharmaceuticals Limited

patent

6. 1 out of 34

Mission Therapeutics Limited

patents

7. 1 out of 24

The Institute of Cancer Research

patents

8. 1 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

where one patent can have more than one assignee

Years Active: 2001-2021

Loading Chart...

Areas of Expertise:

Phthalazinone Derivatives

DNA Damage Repair

Cancer Treatment

ATM Inhibitors

NAT10 Modulators

Laminopathies

Aging

Prokaryotic DNA Repair

Therapeutic Agents

Screening Methods

Cellular Modulation

Retroviral Integration

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11160803 - Phthalazinone derivatives (2021-11-02),

2. 10690656 - Methods of screening and treatment with USP4 inhibitors (2020-06-23),

3. 10449192 - Phthalazinone derivatives (2019-10-22),

4. 9809562 - NAT10 modulators for treating or preventing laminopathies, aging and cancer (2017-11-07),

5. 9566276 - Phthalazinone derivatives (2017-02-14),

6. 9169235 - Phthalazinone derivatives (2015-10-27),

7. 8912187 - Phthalazinone derivatives (2014-12-16),

8. 8143241 - DNA damage repair inhibitors for treatment of cancer (2012-03-27),

9. 8071579 - DNA damage repair inhibitors for the treatment of cancer (2011-12-06),

10. 8034587 - Prokaryotic DNA repair ligases (2011-10-11),

11. 7981889 - Phthalazinone derivatives (2011-07-19),

12. 7662818 - Phthalazinone derivatives (2010-02-16),

13. 7449464 - Phthalazinone derivatives (2008-11-11),

14. 7138236 - Interactions of ATM, ATR or DAN-PK with p53 (2006-11-21),

15. 7049313 - ATM inhibitors (2006-05-23),

Title: Stephen Philip Jackson - Innovator from Cambridge, GB

Introduction: Stephen Philip Jackson is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Stephen Philip Jackson holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the industry, Stephen Philip Jackson has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, Stephen Philip Jackson has collaborated with top universities, tech companies, and research institutions worldwide, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and inventions.

Conclusion: Stephen Philip Jackson's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of technology, inspiring the next generation of inventors and pushing the boundaries of what is possible in the ever-evolving landscape of innovation.

Profile summary based on public USPTO records.